Positive allosteric modulators of the a7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596

被引:0
作者
Acker, Brad A. [1 ]
Badescu, Valentina O. [1 ]
Berkenpas, Mitchell B. [1 ]
Groppi, Vincent E. [1 ]
Hajos, Mihaly [1 ]
Higdon, Nicole R. [1 ]
Hurst, Raymond S. [1 ]
Jacobsen, E. Jon [1 ]
Margolis, Brandon J. [1 ]
Mcwhorter, William W. [1 ]
Myers, Jason K. [1 ]
Piotrowski, David W. [1 ]
Rogers, Bruce N. [1 ]
Sarapa, Dusan [1 ]
Vetman, Tatiana N. [1 ]
Walker, Daniel P. [1 ]
Wall, Theron M. [1 ]
Wilhite, David M. [1 ]
Wishka, Donn G. [1 ]
Xu, Wenjian
Yates, Karen M.
机构
[1] Pfizer Worldwide Res & Dev, Groton, CT 06340 USA
关键词
nAChR; Allosteric; PAM; IN-VITRO; DISCOVERY; SYSTEM;
D O I
10.1016/j.bmcl.2023.129433
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The & alpha;7 nicotinic acetylcholine receptor is a calcium permeable, ligand-gated ion channel that modulates synaptic transmission in the hippocampus, thalamus, and cerebral cortex. Previously disclosed work described PNU-120596 that acts as a powerful positive allosteric modulator of the & alpha;7 nicotinic acetylcholine receptor. The initial structure-activity relationships around PNU-120596 were gleaned from screening a large thiazole library. Independent systematic examination of the aryl and heteroaryl groups resulted in compounds with enhanced potency and improved physico-chemical properties culminating in the identification of 16 (PHA-758454). In the presence of acetylcholine, 16 enhanced evoked currents in rat hippocampal neurons. In a rat model of impaired sensory gating, treatment with 16 led to a reversal of the gating deficit in a dose-dependent manner. These results demonstrate that aryl heteroaryl ureas, like compound 16, may be useful tools for continued exploration of the unique biology of the & alpha;7 nicotinic acetylcholine receptor.
引用
收藏
页数:6
相关论文
共 30 条
  • [1] Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review
    Antonio-Tolentino, Kirsten
    Hopkins, Corey R.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (06) : 603 - 609
  • [2] Berkenpas M. B., Patent No. [US6,693,172, 6693172]
  • [3] Allosteric modulation of nicotinic acetylcholine receptors
    Bertrand, Daniel
    Gopalakrishnan, Murali
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : 1155 - 1163
  • [4] The wonderland of neuronal nicotinic acetylcholine receptors
    Bertrand, Daniel
    Terry, A. V., Jr.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2018, 151 : 214 - 225
  • [5] Discovery and structure -: Activity relationship of quinuclidine benzamides as agonists of α7 nicotinic acetylcholine receptors
    Bodnar, AL
    Cortes-Burgos, LA
    Cook, KK
    Dinh, DM
    Groppi, VE
    Hajos, M
    Higdon, NR
    Hoffmann, WE
    Hurst, RS
    Myers, JK
    Rogers, BN
    Wall, TM
    Wolfe, ML
    Wong, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) : 905 - 908
  • [6] Molecular function of 7 nicotinic receptors as drug targets
    Bouzat, Cecilia
    Lasala, Matias
    Elizabeth Nielsen, Beatriz
    Corradi, Jeremias
    del Carmen Esandi, Maria
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2018, 596 (10): : 1847 - 1861
  • [7] In vitro models for the blood-brain barrier
    Garberg, P
    Ball, M
    Borg, N
    Cecchelli, R
    Fenart, L
    Hurst, RD
    Lindmark, T
    Mabondzo, A
    Nilsson, JE
    Raub, TJ
    Stanimirovic, D
    Terasaki, T
    Öberg, JO
    Österberg, T
    [J]. TOXICOLOGY IN VITRO, 2005, 19 (03) : 299 - 334
  • [8] The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry
    Ghosh, Arun K.
    Brindisi, Margherita
    Sarkar, Anindya
    [J]. CHEMMEDCHEM, 2018, 13 (22) : 2351 - 2373
  • [9] Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes
    Gronlien, Jens Halvard
    Hakerud, Monika
    Ween, Hilde
    Thorin-Hagene, Kirsten
    Briggs, Clark A.
    Gopalakrishnan, Murali
    Malysz, John
    [J]. MOLECULAR PHARMACOLOGY, 2007, 72 (03) : 715 - 724
  • [10] Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
    Hajos, Mihaly
    Rogers, Bruce N.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (05) : 538 - 554